Free Submission Public Relations &
Deutsch English


Report Published: "Cubist Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report"

Print article Print article
2014-01-25 18:39:34 - Fast Market Research recommends "Cubist Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report" from MarketLine, now available

Cubist Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360deg view of the company.

This Report Features:

* Detailed information on Cubist Pharmaceuticals, Inc. required for business and competitor intelligence needs
* A study of the major internal and external factors affecting Cubist Pharmaceuticals, Inc. in the form of a SWOT analysis
* An in-depth view of the business model of Cubist Pharmaceuticals, Inc. including a breakdown and examination of key business segments
* Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and

key ratios for Cubist Pharmaceuticals, Inc.
* Intelligence on Cubist Pharmaceuticals, Inc.nv's mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
* News about Cubist Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
* Large number of easy-to-grasp charts and graphs that present important data and key trends

Full Report Details at
- ..

Report Highlights:

Cubist Pharmaceuticals (Cubist or 'the company') is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. The company operates primarily in the US. Cubist is headquartered in Lexington, Massachusetts and employed 669 people as of February 01, 2012. The company recorded revenues of $754 million during the financial year ended December 2011 (FY2011), an increase of 18.5% over FY2010. The operating profit of the company was $132.5 million in FY2011, a decrease of 30.1% over FY2010. The net profit was $33 million in FY2011, a decrease of 65% over FY2010.

Reasons to Get this Report:

* Gain understanding of Cubist Pharmaceuticals, Inc. and the factors that influence its strategies
* Track strategic initiatives of the company and latest corporate news and actions
* Assess Cubist Pharmaceuticals, Inc. as a prospective partner, vendor or supplier
* Support sales activities by understanding your customers' businesses better
* Stay up to date on Cubist Pharmaceuticals, Inc.'s business structure, strategy and prospects

Companies Mentioned in this Report: Cubist Pharmaceuticals, Inc.

Partial Table of Contents:

Company Snapshot
-Cubist Pharmaceuticals, Inc.: Company Overview
-Cubist Pharmaceuticals, Inc.: Overview and Key Facts
--Cubist Pharmaceuticals, Inc.: Overview
--Cubist Pharmaceuticals, Inc.: Key Facts
-Cubist Pharmaceuticals, Inc.: Key Employees
-Cubist Pharmaceuticals, Inc.: Key Employee Biographies
-Cubist Pharmaceuticals, Inc.: Major Products and Services
-Cubist Pharmaceuticals, Inc.: Company History
-Cubist Pharmaceuticals, Inc.: Management Statement
-Cubist Pharmaceuticals, Inc.: Key Competitors
Cubist Pharmaceuticals, Inc.: Company Analysis
-Cubist Pharmaceuticals, Inc.: Business Description
-Cubist Pharmaceuticals, Inc.: SWOT Analysis
--Cubist Pharmaceuticals, Inc.: SWOT Overview
--Cubist Pharmaceuticals, Inc.: Strengths
--Cubist Pharmaceuticals, Inc.: Weaknesses
--Cubist Pharmaceuticals, Inc.: Opportunities
--Cubist Pharmaceuticals, Inc.: Threats
-Cubist Pharmaceuticals, Inc.: Corporate Financial Deals Activity
-Cubist Pharmaceuticals, Inc.: Financial Deals Overview
-Cubist Pharmaceuticals, Inc.: Targets and Partners
-Cubist Pharmaceuticals, Inc.: Top Deals 2010 - 2014YTD*
-Cubist Pharmaceuticals, Inc.: Advisors
--Cubist Pharmaceuticals, Inc.: Top Legal Advisors
--Cubist Pharmaceuticals, Inc.: Top Financial Advisors
-Cubist Pharmaceuticals, Inc.: Mergers and Acquisitions
-Cubist Pharmaceuticals, Inc.: Capital Raising
-Cubist Pharmaceuticals, Inc.: Partnership
Cubist Pharmaceuticals, Inc.: Recent Developments
-Cubist Pharmaceuticals, Inc.: News and Events Summary
-Cubist Pharmaceuticals, Inc.: Corporate Governance
-Cubist Pharmaceuticals, Inc.: Financial Deals
-Cubist Pharmaceuticals, Inc.: Financial Performance
-Cubist Pharmaceuticals, Inc.: Regulatory and Legal Events
-Cubist Pharmaceuticals, Inc.: Research & Development
-Contact Us
-About Datamonitor

List of Tables

Table 1: Cubist Pharmaceuticals, Inc.: Key Facts
Table 2: Cubist Pharmaceuticals, Inc.: Key Employees
Table 3: Cubist Pharmaceuticals, Inc.: Key Competitors
Table 4: Cubist Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 5: Cubist Pharmaceuticals, Inc.: M&A Activity by Geography (TTM*)
Table 6: Cubist Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2010 - YTD*2014)
Table 7: Cubist Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m)
Table 8: Cubist Pharmaceuticals, Inc.: Targets and Partners
Table 9: Cubist Pharmaceuticals, Inc.: Top Deals 2010 - 2014YTD*
Table 10: Cubist Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: Cubist Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: Cubist Pharmaceuticals, Inc.: M&A Volume and Value Trend (2010 - YTD*2014)
Table 13: Cubist Pharmaceuticals, Inc.: M&A Activity by Geography (2010 - YTD*2014)
Table 14: Cubist Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2010 - YTD*2014)
Table 15: Cubist Pharmaceuticals, Inc.: Capital Raising by Deal Type (2010 - YTD*2014)
Table 16: Cubist Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2010 - YTD*2014)
Table 17: Cubist Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2010 - YTD*2014)

Full Table of Contents is available at:

About MarketLine

MarketLine is a global publisher of company, industry and country information. Their clients operate across a wide variety of industries and job functions and range from multinational corporations right down to small businesses in both developed and developing economies. MarketLine users enjoy access to content that is trustworthy, up to date and reasonably priced and routinely turn to them as their first-stop resource for instantly accessible, reliable business information. View more research from MarketLine at

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Bill Thompson
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact